Dale Abel
Tue 21 14:30
S30.1
Symposium 30: Personalised medicine in diabetes and obesity
Mechanisms for Cardiovascular Complications of Diabetes – Implications for Personalized Therapy
Julio Abucham
Tue 21 08:00
MTE16.1
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Peter Aldiss
Mon 20 10:20
S15.1
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Welcome and Introduction to EYES
Dr Cynthia Andoniadou
London, UK
Mon 20 15:30
S17.2
Symposium 17: Where Do Pituitary Tumours Come From
Pertubations in novel signalling pathways
London, UK
Carmen Aresta
Mon 20 12:00
OC7.1
Oral Communications 7: Endocrine Connections
Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
Alberto Arias
Mon 20 13:00
ERN1.1
Endo-ERN Session - Lunch Hub
Introduction and update on Endo-ERN
Mai Arlien-Søborg
Sun 19 12:36
OC3.4
Oral Communications 3: Cushing's and acromegaly
Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
Guillaume Assie
Tue 21 09:50
S24.1
Symposium 24: What's new in the Adrenal Cortex?
New genes, new understanding, new therapy
Marta Astigarraga
Sun 19 12:00
OC4.1
Oral Communications 4: Thyroid 2
Subclinical hypothyroidism throughout pregnancy in TPOAb positive pregnant women
Fereidoun Azizi
Mon 20 15:30
S16.2
Symposium 16: Thyroid in pregnancy
Thyroid disease and pregnancy outcomes
Elizabeth Baranowski
Tue 21 11:30
OC10.1
Oral Communications 10: Adrenal 1
Steroid Metabolomics: A Rapid Computational Approach for Accurate Differentiation of Inborn Disorders of Steroidogenesis.
Anne Barlier
Mon 20 12:36
OC7.4
Oral Communications 7: Endocrine Connections
Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA.
Maria Barreto-Chaves
Tue 21 15:30
S26.3
Symposium 26: Impact of thyroid disease on...
Cardiac hypertrophy
Isabelle Beau
Tue 21 11:54
OC14.3
Oral Communications 14: Sex Hormones
First identification of Bone Morphogenic Protein Receptor variants as a cause of Primary Ovarian Insufficiency
Moncef Benkhalifa
Mon 20 10:20
S11.1
Symposium 11: EDCs and reproduction
Oocytes, Pesticides and IVF
Jerome Bertherat
France
Sun 19 08:05
PEM1.2
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The clinical view of Endocrinology in Europe
France
Laura Bessiène
Mon 20 12:12
OC7.2
Oral Communications 7: Endocrine Connections
Thyroid hormones are new key regulators of glucocorticoid metabolism
J. Betley
Mon 20 10:20
S13.1
Symposium 13: Central Control of Metabolism: Brain rules all
All optics in the metabolic brain
Anneke Beukel
Sun 19 08:25
PEM1.4
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The early-career perspective
Felix Beuschlein
Zürich, Switzerland
Sun 19 08:15
PEM1.3
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The research view of Endocrinology in Europe
Zürich, Switzerland
Martin Bidlingmaier
Tue 21 08:00
MTE16.2
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Christophe Block
Sun 19 08:00
MTE1
Meet The Expert 1: Diabetes, Obesity and Metabolism
The road from flash and continuous glucose monitoring towards closed loop systems in diabetes
Bruce Blumberg
Sun 19 16:00
S7.3
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Obesity
Jens Bollerslev
Mon 20 09:20
EHM1
Plenary: European Hormone Medal Lecture
Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
Susan Bonner-Weir
Sun 19 17:00
PL3
Plenary 3
Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
Benjamin Bouillet
Mon 20 11:05
S15.4
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
The role and cross-talk between incretin hormones and occurrence of Nonalcoholic steatohepatitis
Pierre Bouloux
Tue 21 08:00
MTE13
Meet The Expert 13: Interdisciplinary Endocrinology
Flushing, blushing and sweating
Nadia Bouzehouane
Sun 19 12:24
OC4.3
Oral Communications 4: Thyroid 2
PROGNOSTIC IMPACT OF MICROSCOPIC EXTRATHYROIDAL EXTENSION (mETE) ON RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PAPILLARY THYROID CARCINOMA (PTC)
Jens Brüning
Tue 21 17:00
PL7
Plenary 7
Diving into the brain basis of obesity/brain/periphery cross-talk in the regulation of peripheral metabolism
Anca Bucur
Mon 20 14:00
NSA4
New Scientific Approach 4
When will AI take over from the endocrinologist?
Alexandre Buffet
Mon 20 12:00
OC5.1
Oral Communications 5: Adrenal 2
Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma
Edit Buzás
Tue 21 09:50
D4.1
Debate 4: MicroRNAs as hormones?
FOR: MicroRNAs and extracellular vesicles as hormones?
Pauline Campos
Tue 21 13:30
NSA6
New Scientific Approach 6
Brain imaging in conscious mice
Carsten Carlberg
Tue 21 13:30
NSA5
New Scientific Approach 5
Genome-wide effects of vitamin D on chromatin
Davide Carvalho
Mon 20 08:00
MTE7
Meet The Expert 7: Pituitary and Neuroendocrinology
Non functional Pituitary Tumours - not always easy
Felipe Casanueva
Sun 19 11:20
SS1.3
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Social economic impact of the globesity pandemic
Olivera Casar-Borota
Mon 20 12:00
D3.1
Debate 3: Pituitary Pathology: Do we care?
FOR: Yes, we care about pituitary pathology
Dr Ruth Casey
Cambridge, United Kingdom
Sun 19 12:00
OC1.1
Oral Communications 1: Calcium and Bone
Genetic testing for hereditary hyperparathyroidism in a large UK cohort
Cambridge, United Kingdom
Ashley Castellanos
Mon 20 10:45
S15.3
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Mon 20 12:24
OC6.3
Oral Communications 6: Obesity 1
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Patrizio Caturegli
Sun 19 11:20
S4.1
Symposium 4: Immunology and endocrinology
Basic: Immunotherapy and endocrine disease
Isadora Cavalcante
Tue 21 12:06
OC10.4
Oral Communications 10: Adrenal 1
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Carlos Celis-Morales
Mon 20 15:00
S20.1
Symposium 20: News on Nutrition: When to eat what
Precision Nutrition for managing obesity – Does it work?
Houaria Chanson
Sun 19 15:45
NDP1.4
Nurses Session 3: Professional Development
Parallel Workshops - MY DIABBY – Improving skills and competence in diabetes education
Kristina Chen
Sun 19 12:36
OC1.4
Oral Communications 1: Calcium and Bone
Risk of Sepsis, Respiratory Infections, and Kidney or Other Genitourinary (GU) Infections in Patients with Chronic Hypoparathyroidism (HypoPT): A Retrospective Cohort Study
Iacopo Chiodini
Tue 21 10:50
S24.3
Symposium 24: What's new in the Adrenal Cortex?
Autonomous cortisol secretion has cardiovascular consequences
Emanuel Christ
Mon 20 10:20
S14.1
Symposium 14: Innovations in NETs
Innovative imaging of insulinoma: The end of sampling…
Professor Mirjam Christ-Crain
Basel, Switzerland
Sat 18 18:20
EJE1
Plenary: European Journal of Endocrinology Award Lecture
New approaches in the differential diagnosis of Diabetes insipidus
Basel, Switzerland
Hye Chung
Tue 21 11:54
OC11.3
Oral Communications 11: Diabetes 2
Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
Marc Claret
Mon 20 10:50
S13.2
Symposium 13: Central Control of Metabolism: Brain rules all
Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
Cyrille Confavreux
Tue 21 08:00
MTE12
Meet The Expert 12: Calcium and Bone
Fracture risk prediction in benign and tumoral bone: new insights
Martine Cools
Ghent, Belgium
Sun 19 15:30
S8.2
Symposium 8: Gender dysphoria
Gender Dysphoria –management of puberty
Ghent, Belgium
Eva Coopmans
Sun 19 12:48
OC3.5
Oral Communications 3: Cushing's and acromegaly
T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
Sabrina Corbetta
Sun 19 12:24
OC1.3
Oral Communications 1: Calcium and Bone
MENIN AND EZH2 ACTIVITIES MODULATE THE EXPRESSION OF THE LONG NON-CODING RNA HAR1B IN PARATHYROID TUMORS
Valérie Cormier-Daire
Paris, France
Tue 21 10:20
S21.2
Symposium 21: Rare Bone Disorders
New perspectives on the treatment of skeletal dysplasia
Paris, France
Mr Sherwin Criseno
Birmingham, UK
Sun 19 11:30
NS1.3
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
The Role of the Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathies
Birmingham, UK
Daisy Crispim
Tue 21 12:06
OC11.4
Oral Communications 11: Diabetes 2
MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
Dr Rachel Crowley
Dublin, Ireland
Mon 20 10:55
NPD2.2
Nurses Session 4: Parathyroid Disorders
Hyperparathyroidism: Evidence-based screening and management
Dublin, Ireland
Michael Culler
Mon 20 12:00
OC6.1
Oral Communications 6: Obesity 1
Impaired Glucose Homeostasis in Leptin-Deficient ob/ob Mice is Corrected by AZP-3404, a 9-Amino Acid Peptide Analog Derived from Insulin-Like Growth Factor-Binding Protein 2, a Key Mediator of Leptin Action
Thomas Cuny
Mon 20 11:45
S15.6
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Closing remarks
Birgitte Damholt
Tue 21 12:06
OC13.4
Oral Communcations 13: Anteria and posteria pituitary
Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
Alberto Davalos
Tue 21 09:50
D4.2
Debate 4: MicroRNAs as hormones?
AGAINST: MicroRNAs as hormones?
Justine Defreyne
Tue 21 12:18
OC12.5
Oral Communications 12: Endocrine Connections 2
Sexual desire in transgender persons in relation with gender affirming hormone treatment. Results from ENIGI, a large multicenter prospective cohort study in transgender people
Tue 21 11:42
OC14.2
Oral Communications 14: Sex Hormones
The effect of testosterone therapy on serum oestradiol levels in transgender men
Olaf Dekkers
Tue 21 10:50
PS1.3
Publishing Session
European Journal of Endocrinology - ‘Common methodological flaws and how to avoid them’
Jacques Drouin
Montreal, Canada
Mon 20 15:00
S17.1
Symposium 17: Where Do Pituitary Tumours Come From
Specification of cell fate
Montreal, Canada
Laurence Dumeige
Tue 21 11:42
OC12.2
Oral Communications 12: Endocrine Connections 2
Epigenetic Programming of Transgenerational Hypertension in Preterm Birth Mice
Maeve Durkan
Tue 21 11:45
UEMS1.1
UEMS Session
The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
Graeme Eisenhofer
Dresden , Germany
Sun 19 15:30
S9.1
Symposium 9: Controversies in adrenal disease
Metanephrines - plasma or urine?
Dresden , Germany
Eva- Erfurth
Mon 20 11:20
S12.3
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
How to manage the long-term consequences of hypothalamic damages
Eda Ertorer
Mon 20 08:00
MTE10
Meet The Expert 10: Reproductive Endocrinology
NCAH and Female reproduction
Patrick Fénichel
Mon 20 10:50
S11.2
Symposium 11: EDCs and reproduction
Testicular germ cell cancer: role of fœtal exposure to endocrine disruptors
Fernando Fernandez-Aranda
Sun 19 12:00
C1.1
Controversies Session: Food addiction in humans: to be or not to be?
Food addiction in humans: to be or not to be?
Serge Ferrari
Tue 21 14:30
D5.1
Debate 5: Should we treat young osteoporotic patients
FOR: Yes, we should treat young osteoporotic patients
Anna Ferrulli
Mon 20 12:12
OC6.2
Oral Communications 6: Obesity 1
Deep Transcranial Magnetic Stimulation modulates body temperature in obesity
Panagiotis Filis
Tue 21 10:50
S25.3
Symposium 25: Late breaking
Maternal smoking and high BMI disrupt thyroid gland development
Jean Fini
Sun 19 15:00
S7.1
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Thyroid
Antonella Forlino
Pavia, Italy
Tue 21 09:50
S21.1
Symposium 21: Rare Bone Disorders
Animal model of bone fragility
Pavia, Italy
Paolo Forni
Mon 20 15:00
S18.1
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
GnRH migration and vomeronasal neurons
Christelle Fouchardiere
Sun 19 10:20
NS1.1
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Overview of Immunotherapy: Indications and adverse effects
Athanasios Fountas
Birmingham, UK
Sun 19 12:12
OC3.2
Oral Communications 3: Cushing's and acromegaly
Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres
Birmingham, UK
Meir Frankel
Sun 19 12:12
OC4.2
Oral Communications 4: Thyroid 2
Thyroid Dysfunction And Mortality In Cardiovascular Hospitalized Patients – A 12 year Follow-up Observational Study
Delphine Franssen
Mon 20 12:00
OC8.1
Oral Communications 8: Reproduction 1
Dissecting the roles of KNDy-derived kisspeptins in the control of reproduction: Generation and characterization of the Tac2-specific Kiss1 KO (TaK-KO) mouse
Graeme Fraser
Mon 20 12:48
OC8.5
Oral Communications 8: Reproduction 1
The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: Responder Analysis Results From a Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study
Avi Friedman
Sat 18 19:00
PL1
Plenary 1
Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
Laura Fugazzola
Sun 19 10:20
S1.1
Symposium 1: Thyroid in cancer
What is the value of molecular markers in nodules
Jorge García-Giménez
Mon 20 12:00
OC9.1
Oral Communications 9: Thyroid 1
3D mapping and in silico predictions of the DEHAL1 enzyme as a tool to discriminate pathogenic mutations from non-functional variants in hypothyroidism
Chiranjit Ghosh
Sun 19 12:24
OC2.3
Oral Communications 2: Diabetes 1
Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes
Andrea Giustina
Sun 19 08:00
PEM1.1
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Introduction: Why Policy and Advocacy matters, also to endocrinology - Includes methodology, response, demographics
Sun 19 08:35
PEM1.5
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Closing remarks and discussion
Dorte Glintborg
Tue 21 12:06
OC14.4
Oral Communications 14: Sex Hormones
Thyroid diseases in Danish women with polycystic ovary syndrome.
Lars Gormsen
Sun 19 08:00
MTBS1
Meet The Basic Scientist 1: Interdisciplinary Endocrinology
New tracers for PET in humans and rodents: Hopes, aims and current evidence
Laura Graaff
Tue 21 08:00
MTE14
Meet The Expert 14: Interdisciplinary Endocrinology
How multidisciplinary care and tailor-made transition save lives of young adults with Prader-Willi syndrome
Claus Gravholt
Mon 20 08:00
MTE8
Meet The Expert 8: Reproductive Endocrinology
Co-morbidities in Turner syndrome
Claus Gravholt
Tue 21 12:18
OC14.5
Oral Communications 14: Sex Hormones
The pattern of cancer occurrence in Turner syndrome
Nuria Guanabens
Tue 21 08:00
MTE11
Meet The Expert 11: Calcium and Bone
Shifting treatment paradigms in osteoporosis
Keren Halpern
Sun 19 14:00
NSA2
New Scientific Approach 2
Single cell spatial reconstruction of endocrine organs
Erin Hanlon
Sun 19 10:50
SS1.2
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Sleep Deficiency: A Pathway to Obesity
Shelley Harris
Sun 19 12:48
OC2.5
Oral Communications 2: Diabetes 1
5β-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo
Anna Hawkins
Sun 19 15:30
NPD1.2
Nurses Session 3: Professional Development
2018 Poster Award Presentation: Testosterone replacement: 'The best practice' and the role of the Endocrine Nurse
Ansgar Heck
Mon 20 10:20
NPD2.1
Nurses Session 4: Parathyroid Disorders
Hypoparathyroidism: Aetiology, diagnosis and challenges in management
James Hennessey
Mon 20 10:20
D2.2
Debate 2: T4 is not enough
AGAINST: No, T4 is enough
Angelica Hirschberg
Stockholm, Sweden
Tue 21 14:30
S29.1
Symposium 29: Endocrine controversies in sport
Female hyperandrogenism and elite sport
Stockholm, Sweden
Jeff Holly
Sun 19 10:20
SS1.1
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Obesity gives you cancer: the bigger picture!
Dr Sasha Howard
London, UK
Sun 19 11:20
S2.3
Symposium 2: Trends in Puberty
Genetic basis in puberty
London, UK
Linda Humbert
Mon 20 12:48
OC7.5
Oral Communications 7: Endocrine Connections
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome : French prospective study in a cohort of 25 patients
Professor Eystein Husebye
Bergen, Norway
Mon 20 15:00
S19.1
Symposium 19: Adrenal Insufficiency
New insights into autoimmune adrenal insufficiency

Unknown speaker

Bergen, Norway
Mirela Ilie
Tue 21 12:00
UEMS1.3
UEMS Session
The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells
María Insenser
Tue 21 09:50
S23.1
Symposium 23: PCOS: Can we personalise treatment?
Gut brain axis
Andrea Isidori
Sun 19 10:50
S3.2
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Fixing the Broken Clock in Adrenal Disorders
Arnaud Jannin
Mon 20 12:36
OC6.4
Oral Communications 6: Obesity 1
Fat mass impact of Sirolimus after clinical islet transplantation, a case control study
Emmanuele Jannini
Sun 19 15:00
S8.1
Symposium 8: Gender dysphoria
Psychoendocrinology Of Gender Dysphoria
John-Olov Jansson
Tue 21 08:00
MTBS3
Meet The Basic Scientist 3
The “Gravitostat” – How does it relate to hormones?
Andrzej Januszewicz
Sun 19 08:00
MTE3
Meet The Expert 3: Adrenal and Neuroendocrine Tumours
The management of primary aldosteronism
Professsor Kassim Javaid
Oxford, UK
Tue 21 10:50
S21.3
Symposium 21: Rare Bone Disorders
Osteogenesis imperfecta throughout life
Oxford, UK
Juan Jiménez-Vacas
Mon 20 12:24
OC5.3
Oral Communications 5: Adrenal 2
SF3B1 as novel target for the treatment of multiple endocrine-related cancers
Gudmundur Johannsson
Mon 20 15:30
S19.2
Symposium 19: Adrenal Insufficiency
Long-term results of slow acting glucocorticoids - are they really better?
Tareq Juratli
Mon 20 10:50
S12.2
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
New potential treatment alternatives in patients with papillary craniopharyngioma
Professor George Kahaly
Mianz, Germany
Tue 21 08:50
PL6
Plenary 6
Treatment strategies for Graves orbitopathy
Mianz, Germany
Peter Kamenicky
Mon 20 16:00
S17.3
Symposium 17: Where Do Pituitary Tumours Come From
From Lab to Clinic - Can we translate into effective therapeutics
Olle Kämpe
Stockholm, Sweden
Sun 19 11:00
S4.3
Symposium 4: Immunology and endocrinology
Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders
Stockholm, Sweden
Yasmine Kemkem
Mon 20 12:48
OC9.5
Oral Communications 9: Thyroid 1
Deciphering the origin of the sexually dimorphic thyrotropin secretion in mouse models.
Marianne Klose
Tue 21 08:00
MTE15
Meet The Expert 15: Pituitary and Neuroendocrinology
To what degree does hypopituitarism exist after TBI?
Tomaz Kocjan
Mon 20 08:00
MTE6
Meet The Expert 6: Calcium and Bone
Primary Hyperparathyroidism: Surgical vs Medical Therapy
Josef Koehrle
Tue 21 09:50
PS1.1
Publishing Session
Endocrine Connections - ‘Increase the visibility of your research: open access and more’
Nils Krone
Sheffield, UK
Mon 20 16:00
S19.3
Symposium 19: Adrenal Insufficiency
Optimising care delivery in Congenital Adrenal Hyperplasia
Sheffield, UK
Irene Lambrinoudaki
Tue 21 15:30
S27.3
Symposium 27: What's new in reproductive endocrinology?
Menopause and cardiovascular risk
Matthias Laudes
Sun 19 11:20
S5.3
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Targeted Microbiome Intervention for handling insulin resistance
Laurence Leenhardt
Sun 19 08:00
MTE5
Meet The Expert 5: Thyroid
Risk classification of thyroid nodules by ultrasound and indications for FNA
Hervé Lefebvre
Mon 20 17:20
PL5
Plenary 5
Paracrine regulation of the adrenal cortex
Bernard Lerer
Tue 21 14:30
S26.1
Symposium 26: Impact of thyroid disease on...
Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders
Deborah Levie
Mon 20 16:00
S16.3
Symposium 16: Thyroid in pregnancy
Thyroid disease and offspring development
Jean Lifante
Mon 20 11:30
NPD2.3
Nurses Session 4: Parathyroid Disorders
Parathyroid Surgery: Indications and Consequences
Qiaoran Liu
Sun 19 12:12
OC2.2
Oral Communications 2: Diabetes 1
Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
Dr Sofia Llahana
London, UK
Sun 19 15:00
NPD1.1
Nurses Session 3: Professional Development
Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards
London, UK
Sun 19 15:45
NPD1.3
Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)
London, UK
Alejandro Lomniczi
Sun 19 10:20
S2.1
Symposium 2: Trends in Puberty
Exploring the Epigenetic Landscape of Puberty
Miguel López
Tue 21
EYIJC2
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
Role of hypothalamic AMP-activated protein kinase (AMPK) in the central regulation of energy balance
Andrea Lovdel
Mon 20 10:25
S15.2
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Investigating glucocorticoids as the mechanism behind bone marrow adiposity expansion during caloric restriction
Raul Luque
Tue 21 10:50
S22.3
Symposium 22: The Pituitary As Metabolic Sensor
Bidirectional interrelationship between growth hormone and metabolism
Djuro Macut
Sun 19 12:00
ECAS1.1
ESE Council of Affiliated Societies Session
Mapping Endocrinology in Europe - ECAS report
Katharina Main
Copenhagen, Denmark
Mon 20 11:20
S11.3
Symposium 11: EDCs and reproduction
Mitigating against endocrine disruption in pregnancy
Copenhagen, Denmark
Sari Mäkimattila
Sun 19 12:00
OC2.1
Oral Communications 2: Diabetes 1
EVERY FIFTH PATIENT WITH TYPE 1 DIABETES SUFFERS FROM AN ADDITIONAL ENDOCRINOLOGICAL AUTOIMMUNE DISEASE – A FINNISH NATIONWIDE STUDY
Beata Malachowska
Mon 20 11:25
S15.5
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Lysophosphatidic acid in pathogenesis of HNF1B-MODY syndrome
Claudio Marcocci
Sun 19 16:00
S10.3
Symposium 10: Cancer drug-induced osteoporosis
TSH-suppressive therapy and bone
Pedro Marques
Tue 21 11:54
OC13.3
Oral Communcations 13: Anteria and posteria pituitary
Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype
George Mastorakos
Sun 19 12:20
ECAS1.2
ESE Council of Affiliated Societies Session
Centres of special interest - how could we move on?
Professor Chris McCabe
Birmingham, UK
Sun 19 10:50
S1.2
Symposium 1: Thyroid in cancer
Iodine refractoriness in thyroid cells
Birmingham, UK
Marco Medici
Sun 19 15:00
S6.1
Symposium 6: A better life with thyroid hormone
Prediction of the thyroid axis set-point
Emilie Merlen
Tue 21 12:06
OC12.4
Oral Communications 12: Endocrine Connections 2
Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France
Michal Meron
Mon 20 12:48
OC6.5
Oral Communications 6: Obesity 1
Lipolysis Defect in White Adipose Tissue and Rapid Weight Regaining
Andrea Messina
Mon 20 15:30
S18.2
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Flipping the GnRH switch with microRNAs
Radu Mihai
Sun 19 15:00
S9.3
Symposium 9: Controversies in adrenal disease
Is there a role for subtotal adrenalectomy
Gesthimani Mintziori
Tue 21 10:20
PS1.2
Publishing Session
EDM Case Reports - ‘Top tips for writing and submitting an article – an early career researcher’s perspective’
Nicolas Morel-Journel
Sun 19 16:00
S8.3
Symposium 8: Gender dysphoria
Gender reassignment surgery in dysphoria
Daniel Morganstein
London, UK
Sun 19 10:55
NS1.2
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring
London, UK
Angel Nadal
Sun 19 15:30
S7.2
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Diabetes Mellitus
Narjes Nasiri-Ansari
Sun 19 12:36
OC2.4
Oral Communications 2: Diabetes 1
Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice
Victor Navarro
Tue 21 09:50
S22.1
Symposium 22: The Pituitary As Metabolic Sensor
Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis
Mario Neou
Tue 21 12:18
OC13.5
Oral Communcations 13: Anteria and posteria pituitary
Pan-genomic classification of Pituitary Adenomas
Romana Netea-Maier
Sun 19 12:48
OC4.5
Oral Communications 4: Thyroid 2
A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project
Hannah Nieto
Birmingham, United Kingdom
Mon 20 12:24
OC9.3
Oral Communications 9: Thyroid 1
Novel driver mutations in thyroid cancer recurrence
Birmingham, United Kingdom
Max Nieuwdorp
Sun 19 10:50
S5.2
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Fecal transplantation: Myth or reality
Ruth Northway
Sun 19 12:00
MTNE1
Nurses Session 2: Meet the Nurse Expert
Nursing Approach To The Holistic Care of Patients with Intellectual Disability
Birte Nygaard
Mon 20 10:20
D2.1
Debate 2: T4 is not enough
FOR: Yes, T4 is not enough
Barbara Obermayer-Pietsch
Tue 21 14:30
D5.2
Debate 5: Should we treat young osteoporotic patients
AGAINST: No, we shouldn't treat young osteoporotic patients
Ken Ong
Cambridge, United Kingdom
Sun 19 09:20
PL2
Plenary 2
Genetic epidemiology of puberty timing and reproductive lifespan
Cambridge, United Kingdom
Professor Anne-Simone Parent
Liège, Belgium
Sun 19 10:50
S2.2
Symposium 2: Trends in Puberty
Endocrine disruptors in puberty
Liège, Belgium
Valentina Pautasso
Mon 20 12:36
OC9.4
Oral Communications 9: Thyroid 1
Resistance to thyroid hormone alpha associated with early-onset severe NASH
Professor Simon Pearce
Newcastle, UK
Sun 19 16:00
S6.3
Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in the elderly
Newcastle, UK
Sergio Pedraza-Arévalo
Mon 20 12:36
OC5.4
Oral Communications 5: Adrenal 2
The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy
Mariasara Persano
Tue 21 12:18
OC11.5
Oral Communications 11: Diabetes 2
Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study
Rosario Pivonello
Sun 19 12:00
OC3.1
Oral Communications 3: Cushing's and acromegaly
Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study
Stephanie Puget
Mon 20 10:20
S12.1
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
The view of the surgeon: When, how much and when to refrain from surgery?
Elena Rapizzi
Mon 20 12:12
OC5.2
Oral Communications 5: Adrenal 2
Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved
Giulia Rastrelli
Tue 21 11:30
OC14.1
Oral Communications 14: Sex Hormones
Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
Professor Martina Rauner
Dresden, Germany
Sun 19 15:00
S10.1
Symposium 10: Cancer drug-induced osteoporosis
Mechanisms of skeletal metastasis (could be induced by breast cancer or prostate cancer or both)
Dresden, Germany
Dr David Ray
Manchester, UK
Sun 19 10:20
S3.1
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Circadian control of glucocorticoid function
Manchester, UK
Julie Refardt
Tue 21 11:42
OC13.2
Oral Communcations 13: Anteria and posteria pituitary
Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion – a randomized, double-blind, placebo-controlled trial
Professor Nicole Reisch
Munich, Germany
Sun 19 08:00
MTE4
Meet The Expert 4: Adrenal and Neuroendocrine Tumours
Management of a life-long disease in CAH
Munich, Germany
Lars Rejnmark
Mon 20 13:01
ERN1.2
Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Lucie Renault
Mon 20 12:12
OC8.2
Oral Communications 8: Reproduction 1
AMH is a predictive factor for successful sperm retrieval in non-mosaic Klinefelter syndrome patients
Juan Rivas
Mon 20 12:36
OC8.4
Oral Communications 8: Reproduction 1
Conditional ablation of AMP-Activated Protein Kinase (AMPK) in GnRH Neurons Reveals Specific Roles in Reproductive and Metabolic Homeostasis
Graham Roberts
Waterford, Ireland
Tue 21 11:30
UEMS1.2
UEMS Session
Update on European Exam in Endocrinology
Waterford, Ireland
Denise Robertson
Mon 20 15:30
S20.2
Symposium 20: News on Nutrition: When to eat what
Is limiting the timing of food intake a viable nutritional approach?
Mercedes Robledo
Sun 19 16:00
S9.2
Symposium 9: Controversies in adrenal disease
The do's and don'ts of genetic testing in phaeochromocytoma
David Rodriguez
Mon 20 12:24
OC8.3
Oral Communications 8: Reproduction 1
Endocrine Disruptors transgenerationally alters pubertal timing through epigenetic reprogramming of the hypothalamus.
Dr Cristina Ronchi
Birmingham, United Kingdom
Tue 21 12:18
OC10.5
Oral Communications 10: Adrenal 1
Cyclin Dependent Kinase 4 as promising drug target in adrenocortical carcinoma
Birmingham, United Kingdom
Pim Ronde
Tue 21 15:00
S29.2
Symposium 29: Endocrine controversies in sport
Performance enhancing drugs in young males
Emilio Ros
Mon 20 16:00
S20.3
Symposium 20: News on Nutrition: When to eat what
PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health
Guadalupe Sabio
Tue 21 09:50
S25.1
Symposium 25: Late breaking
Liver Stress kinases – crossroad between obesity and liver cancer (Source paper: Nature 2019)
Prudencio Sáez-Martínez
Tue 21 11:54
OC12.3
Oral Communications 12: Endocrine Connections 2
Neuronostatin and GPR107 system: a novel therapeutic circuit in Prostate Cancer.
Maria Salerno
Sun 19 15:30
S6.2
Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in children
Renato Santini
Mon 20 15:00
GS1
Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
Topics: 'Hormonal alterations in obesity', 'Thyroid dysfunction', 'Hypercortisolism', 'Gonadal dysfunction' & 'cther hormones'
Federica Saponaro
Sun 19 12:12
OC1.2
Oral Communications 1: Calcium and Bone
Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism
Sven Schlaffer
Mon 20 12:00
D3.2
Debate 3: Pituitary Pathology: Do we care?
AGAINST: No, we don't care about pituitary pathology
Martin Schlumberger
Sun 19 11:20
S1.3
Symposium 1: Thyroid in cancer
New paradigms in the treatment of low risk thyroid cancer
Ulrich Schweizer
Mon 20 12:12
OC9.2
Oral Communications 9: Thyroid 1
Direct evidence for disulfides in the mechanism of deiodinase 1
David Selva
Tue 21 11:42
OC11.2
Oral Communications 11: Diabetes 2
Molecular Mechanisms Regulating Hepatic Sex Hormone-Binding Globulin Production. Clinical Implications in Human Diseases.
Jochen Seufert
Tue 21 15:30
S30.3
Symposium 30: Personalised medicine in diabetes and obesity
Curing diabetes with alternatives: bariatric surgery
Mojca Sever
Tue 21 10:50
S23.3
Symposium 23: PCOS: Can we personalise treatment?
Treatment options in cardiometabolic PCOS phenotype
Paul Sibilia
Sun 19 12:36
OC4.4
Oral Communications 4: Thyroid 2
Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France
Heide Siggelkow
Sun 19 12:48
OC1.5
Oral Communications 1: Calcium and Bone
Renal Function in 711 patients with Hypoparathyroidism during more than 4 years of therapy
Anne Skakkebæk
Mon 20 08:00
MTE9
Meet The Expert 9: Reproductive Endocrinology
Co-morbidities in Klinefelter syndrome
Rima Smith
Tue 21 10:20
S25.2
Symposium 25: Late breaking
LT4 treatment and pregnancy outcomes in TPOab positive women: results of the TABLET Trial
Esben Søndergaard
Tue 21
EYIJC1
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
The metabolic effects of SGLT2 inhibitors – Does the increase in ketone bodies protect the heart?
Halfdan Sorbye
Mon 20 10:50
S14.2
Symposium 14: Innovations in NETs
A role for radionuclide therapy for high-grade NETs
Jean Souberbielle
Tue 21 15:30
S28.3
Symposium 28: Vitamin D - non-skeletal effects in RCTs
How and when to measure Vitamin D
Günter Stalla
Sat 18 17:45
GH1
Plenary: Geoffrey Harris Award Lecture
Translational research in pituitary disease
Danielle Steenvoorden
Mon 20 13:02
ERN1.3
Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Maria Stelmachowska-Banas
Sun 19 10:50
S4.2
Symposium 4: Immunology and endocrinology
Clinical: Immunotherapy and endocrine disease
Gabor Tamas
Mon 20 14:00
NSA3
New Scientific Approach 3
Intelligent image based in situ single cell isolation
Sopio Tatulashvili
Tue 21 11:30
OC11.1
Oral Communications 11: Diabetes 2
Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study
Dr Henri Timmers
Nijmegen, The Netherlands
Sun 19 15:15
D1.1
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
FOR: Surgical treatment of phaeochromocytoma - query pre-treatment?
Nijmegen, The Netherlands
Giovanni Tulipano
Tue 21 10:20
S22.2
Symposium 22: The Pituitary As Metabolic Sensor
How treatments with endocrine & metabolic drugs influence pituitary cell function?
Frank Tuttelmann
Tue 21 15:00
S27.2
Symposium 27: What's new in reproductive endocrinology?
Large scale genetic studies in male infertility
David Unuane
Mon 20 15:00
S16.1
Symposium 16: Thyroid in pregnancy
Thyroid autoimmunity and fertility
Anna Vaczlavik
Tue 21 11:54
OC10.3
Oral Communications 10: Adrenal 1
Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (Glucocorticoid Receptor) and PDE11A4 (Phosphodiesterase 11) in 389 patients
Roberto Vettor
Sun 19 08:00
MTE2
Meet The Expert 2: Diabetes, Obesity and Metabolism
Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?
Hubert Vidal
Sun 19 10:20
S5.1
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Human gut microbiome: hopes, threats and promises
Suvi Virtanen
Tue 21 15:00
S28.2
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and Type 1 Diabetes
Giovanni Vitale
Mon 20 11:20
S14.3
Symposium 14: Innovations in NETs
Fishing for NETs
Géraldine Vitellius
Tue 21 11:42
OC10.2
Oral Communications 10: Adrenal 1
Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism
Kirsty Walters
Tue 21 14:30
S27.1
Symposium 27: What's new in reproductive endocrinology?
Dissecting Androgens in PCOS
Professor Martin Walz
Essen, Germany
Sun 19 15:15
D1.2
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
AGAINST: Surgical treatment of phaeochromocytoma - query pre-treatment?
Essen, Germany
Guan Wang
Tue 21 15:30
S29.3
Symposium 29: Endocrine controversies in sport
Omics to fight doping
Susan Webb
Barcelona, Spain
Mon 20 16:50
CET1
Plenary: Clinical Endocrinology Trust Lecture
How can patients perception of outcome be improved after controlling pituitary disease?
Barcelona, Spain
Andrea Widmer
Mon 20 12:48
OC5.5
Oral Communications 5: Adrenal 2
Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients
Professor John Wilding
Liverpool, United Kingdom
Tue 21 15:00
S30.2
Symposium 30: Personalised medicine in diabetes and obesity
New avenues for novel drugs to treat obesity
Liverpool, United Kingdom
Tracy Williams
Tue 21 10:20
S24.2
Symposium 24: What's new in the Adrenal Cortex?
Primary hyperaldosteronism: does our treatment work?
Graham Williams
Tue 21 15:00
S26.2
Symposium 26: Impact of thyroid disease on...
Bone
Elizabeth Winter
Tue 21 11:30
OC12.1
Oral Communications 12: Endocrine Connections 2
Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover
Elisabeth Winter
Tue 21 14:30
S28.1
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and its metabolites
Bettina Winzeler
Tue 21 11:30
OC13.1
Oral Communcations 13: Anteria and posteria pituitary
Arginine-stimulated Copeptin Measurements - A new Test for Diabetes Insipidus
Eckhard Wolf
Mon 20 08:00
MTBS2
Meet The Basic Scientist 2
Genetically tailored pig models in translational endocrine and metabolic research
Professor Stefan Wudy
Giessen, Germany
Sun 19 14:00
NSA1
New Scientific Approach 1
Steroidomics
Giessen, Germany
Chris Yedinak
USA), Lisa Shepherd
Sun 19 15:45
NPD1.5
Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)
USA), Lisa Shepherd
Professor Giles Yeo
Cambridge, UK
Mon 20 11:20
S13.3
Symposium 13: Central Control of Metabolism: Brain rules all
Genetics of appetite regulation
Cambridge, UK
Bulent Yildiz
Sun 19 12:40
ECAS1.3
ESE Council of Affiliated Societies Session
3rd Early Career Clinical Endocrinologist session at EndoBridge 2019 - referring of a patient from primary care to the endocrinology unit
Takashi Yoshimura
Sun 19 11:20
S3.3
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Light Up Your Sex Life!
Jacques Young
Mon 20 16:00
S18.3
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Congenital Hypogonadotropic Hypogonadism: Clinical Perspectives
Jiang-Ning Zhou
Sun 19 12:24
OC3.3
Oral Communications 3: Cushing's and acromegaly
Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale
Volha Zhukouskaya
Mon 20 12:24
OC7.3
Oral Communications 7: Endocrine Connections
HIGHER DOSE OF BUROSUMAB IS NEEDED FOR TREATMENT OF CHILDREN WITH SEVER FORMS OF X-LINKED HYPOPHOSPHATEMIA
Juleen Zierath
Mon 20 08:50
PL4
Plenary 4
Exercise training in the management of T2D
Carola Zillikens
Sun 19 15:30
S10.2
Symposium 10: Cancer drug-induced osteoporosis
Aromatase inhibitors and bone
Sat 18 09:00
Pre-congress Courses
Sun 19 12:00
OC1.1
Oral Communications 1: Calcium and Bone
Genetic testing for hereditary hyperparathyroidism in a large UK cohort
Cambridge, United Kingdom
Sun 19 12:12
OC1.2
Oral Communications 1: Calcium and Bone
Urinary magnesium as predictor of nephrolithiasis in patients with asymptomatic primary hyperparathyroidism
Sun 19 12:24
OC1.3
Oral Communications 1: Calcium and Bone
MENIN AND EZH2 ACTIVITIES MODULATE THE EXPRESSION OF THE LONG NON-CODING RNA HAR1B IN PARATHYROID TUMORS
Sun 19 12:36
OC1.4
Oral Communications 1: Calcium and Bone
Risk of Sepsis, Respiratory Infections, and Kidney or Other Genitourinary (GU) Infections in Patients with Chronic Hypoparathyroidism (HypoPT): A Retrospective Cohort Study
Sun 19 12:48
OC1.5
Oral Communications 1: Calcium and Bone
Renal Function in 711 patients with Hypoparathyroidism during more than 4 years of therapy
Sun 19 12:00
OC2.1
Oral Communications 2: Diabetes 1
EVERY FIFTH PATIENT WITH TYPE 1 DIABETES SUFFERS FROM AN ADDITIONAL ENDOCRINOLOGICAL AUTOIMMUNE DISEASE – A FINNISH NATIONWIDE STUDY
Sun 19 12:12
OC2.2
Oral Communications 2: Diabetes 1
Elevated glucose uptake in skeletal muscle with increased sarcolemma translocation of GLUT4 and glycogen synthesis contributes to bariatric surgery mediated diabetes remission
Sun 19 12:24
OC2.3
Oral Communications 2: Diabetes 1
Identification of oxygen-18 isotope of breath carbon dioxide as a non-invasive marker to distinguish type 1 and type 2 diabetes
Sun 19 12:36
OC2.4
Oral Communications 2: Diabetes 1
Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice
Sun 19 12:48
OC2.5
Oral Communications 2: Diabetes 1
5β-reductase (AKR1D1) deletion drives hepatic inflammation, fibrosis and tumour development in vitro and in vivo
Mon 20 12:00
OC8.1
Oral Communications 8: Reproduction 1
Dissecting the roles of KNDy-derived kisspeptins in the control of reproduction: Generation and characterization of the Tac2-specific Kiss1 KO (TaK-KO) mouse
Mon 20 12:12
OC8.2
Oral Communications 8: Reproduction 1
AMH is a predictive factor for successful sperm retrieval in non-mosaic Klinefelter syndrome patients
Mon 20 12:24
OC8.3
Oral Communications 8: Reproduction 1
Endocrine Disruptors transgenerationally alters pubertal timing through epigenetic reprogramming of the hypothalamus.
Mon 20 12:36
OC8.4
Oral Communications 8: Reproduction 1
Conditional ablation of AMP-Activated Protein Kinase (AMPK) in GnRH Neurons Reveals Specific Roles in Reproductive and Metabolic Homeostasis
Mon 20 12:48
OC8.5
Oral Communications 8: Reproduction 1
The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: Responder Analysis Results From a Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study
Tue 21 11:30
OC10.1
Oral Communications 10: Adrenal 1
Steroid Metabolomics: A Rapid Computational Approach for Accurate Differentiation of Inborn Disorders of Steroidogenesis.
Tue 21 11:42
OC10.2
Oral Communications 10: Adrenal 1
Glucocorticoid resistance patients exhibit defective cortisol metabolism, responsible for functional hypermineralocorticism
Tue 21 11:54
OC10.3
Oral Communications 10: Adrenal 1
Genetic predisposition to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH): next generation sequencing ARMC5, NR3C1 (Glucocorticoid Receptor) and PDE11A4 (Phosphodiesterase 11) in 389 patients
Tue 21 12:06
OC10.4
Oral Communications 10: Adrenal 1
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Tue 21 12:18
OC10.5
Oral Communications 10: Adrenal 1
Cyclin Dependent Kinase 4 as promising drug target in adrenocortical carcinoma
Birmingham, United Kingdom
Sun 19 08:00
MTE1
Meet The Expert 1: Diabetes, Obesity and Metabolism
The road from flash and continuous glucose monitoring towards closed loop systems in diabetes
Sun 19 08:00
MTE2
Meet The Expert 2: Diabetes, Obesity and Metabolism
Long-term endocrine-metabolic effects of bariatric surgery: do the benefits really outweigh the risks?
Sun 19 08:00
MTE3
Meet The Expert 3: Adrenal and Neuroendocrine Tumours
The management of primary aldosteronism
Sun 19 08:00
MTE4
Meet The Expert 4: Adrenal and Neuroendocrine Tumours
Management of a life-long disease in CAH
Munich, Germany
Sun 19 08:00
MTE5
Meet The Expert 5: Thyroid
Risk classification of thyroid nodules by ultrasound and indications for FNA
Sun 19 08:00
MTBS1
Meet The Basic Scientist 1: Interdisciplinary Endocrinology
New tracers for PET in humans and rodents: Hopes, aims and current evidence
Sun 19 12:00
C1.1
Controversies Session: Food addiction in humans: to be or not to be?
Food addiction in humans: to be or not to be?
Sun 19 14:00
NSA1
New Scientific Approach 1
Steroidomics
Giessen, Germany
Sun 19 14:00
NSA2
New Scientific Approach 2
Single cell spatial reconstruction of endocrine organs
Sun 19 15:15
D1.1
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
FOR: Surgical treatment of phaeochromocytoma - query pre-treatment?
Nijmegen, The Netherlands
Sun 19 15:15
D1.2
Debate 1: Surgical treatment of phaeochromocytoma - query pre-treatment?
AGAINST: Surgical treatment of phaeochromocytoma - query pre-treatment?
Essen, Germany
Mon 20 08:00
MTE6
Meet The Expert 6: Calcium and Bone
Primary Hyperparathyroidism: Surgical vs Medical Therapy
Mon 20 08:00
MTE7
Meet The Expert 7: Pituitary and Neuroendocrinology
Non functional Pituitary Tumours - not always easy
Mon 20 08:00
MTE8
Meet The Expert 8: Reproductive Endocrinology
Co-morbidities in Turner syndrome
Mon 20 08:00
MTE9
Meet The Expert 9: Reproductive Endocrinology
Co-morbidities in Klinefelter syndrome
Mon 20 08:00
MTE10
Meet The Expert 10: Reproductive Endocrinology
NCAH and Female reproduction
Mon 20 08:00
MTBS2
Meet The Basic Scientist 2
Genetically tailored pig models in translational endocrine and metabolic research
Mon 20 10:20
D2.2
Debate 2: T4 is not enough
AGAINST: No, T4 is enough
Mon 20 10:20
D2.1
Debate 2: T4 is not enough
FOR: Yes, T4 is not enough
Mon 20 12:00
D3.1
Debate 3: Pituitary Pathology: Do we care?
FOR: Yes, we care about pituitary pathology
Mon 20 12:00
D3.2
Debate 3: Pituitary Pathology: Do we care?
AGAINST: No, we don't care about pituitary pathology
Mon 20 14:00
NSA3
New Scientific Approach 3
Intelligent image based in situ single cell isolation
Mon 20 14:00
NSA4
New Scientific Approach 4
When will AI take over from the endocrinologist?
Tue 21 08:00
MTE11
Meet The Expert 11: Calcium and Bone
Shifting treatment paradigms in osteoporosis
Tue 21 08:00
MTE12
Meet The Expert 12: Calcium and Bone
Fracture risk prediction in benign and tumoral bone: new insights
Tue 21 08:00
MTE13
Meet The Expert 13: Interdisciplinary Endocrinology
Flushing, blushing and sweating
Tue 21 08:00
MTE14
Meet The Expert 14: Interdisciplinary Endocrinology
How multidisciplinary care and tailor-made transition save lives of young adults with Prader-Willi syndrome
Tue 21 08:00
MTE15
Meet The Expert 15: Pituitary and Neuroendocrinology
To what degree does hypopituitarism exist after TBI?
Tue 21 08:00
MTE16.2
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Tue 21 08:00
MTE16.1
Meet The Expert 16: Interdisciplinary Endocrinology
Is it all in your head or just in the lab?
Tue 21 08:00
MTBS3
Meet The Basic Scientist 3
The “Gravitostat” – How does it relate to hormones?
Tue 21 09:50
D4.2
Debate 4: MicroRNAs as hormones?
AGAINST: MicroRNAs as hormones?
Tue 21 09:50
D4.1
Debate 4: MicroRNAs as hormones?
FOR: MicroRNAs and extracellular vesicles as hormones?
Tue 21 13:30
NSA5
New Scientific Approach 5
Genome-wide effects of vitamin D on chromatin
Tue 21 13:30
NSA6
New Scientific Approach 6
Brain imaging in conscious mice
Tue 21 14:30
D5.2
Debate 5: Should we treat young osteoporotic patients
AGAINST: No, we shouldn't treat young osteoporotic patients
Tue 21 14:30
D5.1
Debate 5: Should we treat young osteoporotic patients
FOR: Yes, we should treat young osteoporotic patients
Sat 18 17:45
GH1
Plenary: Geoffrey Harris Award Lecture
Translational research in pituitary disease
Sat 18 18:20
EJE1
Plenary: European Journal of Endocrinology Award Lecture
New approaches in the differential diagnosis of Diabetes insipidus
Basel, Switzerland
Sat 18 19:00
PL1
Plenary 1
Designing Cities and Homes as Exercise Machines: Helping endocrinologists to fight metabolic disease
Sun 19 09:20
PL2
Plenary 2
Genetic epidemiology of puberty timing and reproductive lifespan
Cambridge, United Kingdom
Sun 19 17:00
PL3
Plenary 3
Pancreatic beta-cell ageing: Novel mechanisms and consequences in the management of diabetes
Mon 20 08:50
PL4
Plenary 4
Exercise training in the management of T2D
Mon 20 09:20
EHM1
Plenary: European Hormone Medal Lecture
Monogenic Bone Disorders as a Model for Novel Treatment of Osteoporosis
Mon 20 16:50
CET1
Plenary: Clinical Endocrinology Trust Lecture
How can patients perception of outcome be improved after controlling pituitary disease?
Barcelona, Spain
Mon 20 17:20
PL5
Plenary 5
Paracrine regulation of the adrenal cortex
Tue 21 08:50
PL6
Plenary 6
Treatment strategies for Graves orbitopathy
Mianz, Germany
Tue 21 17:00
PL7
Plenary 7
Diving into the brain basis of obesity/brain/periphery cross-talk in the regulation of peripheral metabolism
Sun 19 09:50
Tea & Coffee
Exhibition area
Sun 19 13:00
Lunch & Poster viewing
Exhibition area
Sun 19 13:00
Nurses Textbook Launch, Lunch and Informal Networking
ECE Hub
Sun 19 16:30
Tea & Coffee
Exhibition area
Mon 20 09:50
Tea & Coffee
Exhibition area
Mon 20 13:00
Lunch & Poster viewing
Exhibition area
Mon 20 13:00
Nurses Poster Viewing and Presentations, Lunch and Informal Networking
Salon Prestige Gratte-Ciel
Tue 21 09:20
Tea & Coffee
Exhibition area
Tue 21 12:30
Lunch & Poster viewing
Exhibition area
Tue 21 16:00
Tea & Coffee
Exhibition area
Sun 19 10:20
NS1.1
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Overview of Immunotherapy: Indications and adverse effects
Sun 19 10:55
NS1.2
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
Immunotherapy-induced Endocrinopathies: Assessment, Management and Monitoring
London, UK
Sun 19 11:30
NS1.3
Nurses Session 1: Immuno-oncology (IO) meets Endocrinology
The Role of the Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathies
Birmingham, UK
Sun 19 12:00
MTNE1
Nurses Session 2: Meet the Nurse Expert
Nursing Approach To The Holistic Care of Patients with Intellectual Disability
Sun 19 15:00
NPD1.1
Nurses Session 3: Professional Development
Update from the ESE Nurses Working Group, future projects and presentation of Poster Awards
London, UK
Sun 19 15:30
NPD1.2
Nurses Session 3: Professional Development
2018 Poster Award Presentation: Testosterone replacement: 'The best practice' and the role of the Endocrine Nurse
Sun 19 15:45
NPD1.5
Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Acromegaly)
USA), Lisa Shepherd
Sun 19 15:45
NDP1.4
Nurses Session 3: Professional Development
Parallel Workshops - MY DIABBY – Improving skills and competence in diabetes education
Sun 19 15:45
NPD1.3
Nurses Session 3: Professional Development
Parallel Workshops - How to use the Textbook in Advanced Endocrine Nursing and Competency Framework to develop your clinical practice (Adrenal Insufficiency)
London, UK
Mon 20 10:20
NPD2.1
Nurses Session 4: Parathyroid Disorders
Hypoparathyroidism: Aetiology, diagnosis and challenges in management
Mon 20 10:55
NPD2.2
Nurses Session 4: Parathyroid Disorders
Hyperparathyroidism: Evidence-based screening and management
Dublin, Ireland
Mon 20 11:30
NPD2.3
Nurses Session 4: Parathyroid Disorders
Parathyroid Surgery: Indications and Consequences
Sat 18 12:00
REGISTRATION
Sat 18 17:00
ECE 2019 Opening Ceremony
L'Amphithéâtre
Sat 18 19:30
Welcome Reception
Exhibition area
Sun 19 07:00
REGISTRATION
Sun 19 08:00
PEM1.1
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Introduction: Why Policy and Advocacy matters, also to endocrinology - Includes methodology, response, demographics
Sun 19 08:05
PEM1.2
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The clinical view of Endocrinology in Europe
France
Sun 19 08:15
PEM1.3
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The research view of Endocrinology in Europe
Zürich, Switzerland
Sun 19 08:25
PEM1.4
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
The early-career perspective
Sun 19 08:35
PEM1.5
Putting Endocrinology on the Map – The voice of 3.111 endocrine clinicians and researchers
Closing remarks and discussion
Sun 19 08:50
Interview with the ESE President and President-Elect
L'Amphithéâtre
Sun 19 12:00
ECAS1.1
ESE Council of Affiliated Societies Session
Mapping Endocrinology in Europe - ECAS report
Sun 19 12:20
ECAS1.2
ESE Council of Affiliated Societies Session
Centres of special interest - how could we move on?
Sun 19 12:40
ECAS1.3
ESE Council of Affiliated Societies Session
3rd Early Career Clinical Endocrinologist session at EndoBridge 2019 - referring of a patient from primary care to the endocrinology unit
Mon 20 07:00
REGISTRATION
Mon 20 13:00
ESE President meets new members
Mon 20 15:00
GS1
Guidelines Session: ESE Clinical Practice Guidelines on the Endocrine Work-up in Obesity
Topics: 'Hormonal alterations in obesity', 'Thyroid dysfunction', 'Hypercortisolism', 'Gonadal dysfunction' & 'cther hormones'
Tue 21 07:00
REGISTRATION
Tue 21 09:50
S25.1
Symposium 25: Late breaking
Liver Stress kinases – crossroad between obesity and liver cancer (Source paper: Nature 2019)
Tue 21 10:20
S25.2
Symposium 25: Late breaking
LT4 treatment and pregnancy outcomes in TPOab positive women: results of the TABLET Trial
Tue 21 10:50
S25.3
Symposium 25: Late breaking
Maternal smoking and high BMI disrupt thyroid gland development
Tue 21 09:50
PS1.1
Publishing Session
Endocrine Connections - ‘Increase the visibility of your research: open access and more’
Tue 21 10:20
PS1.2
Publishing Session
EDM Case Reports - ‘Top tips for writing and submitting an article – an early career researcher’s perspective’
Tue 21 10:50
PS1.3
Publishing Session
European Journal of Endocrinology - ‘Common methodological flaws and how to avoid them’
Tue 21 11:30
UEMS1.2
UEMS Session
Update on European Exam in Endocrinology
Waterford, Ireland
Tue 21 11:45
UEMS1.1
UEMS Session
The role of UEMS in Europe and the distinct and independent but allied pathway with ESE
Tue 21 12:00
UEMS1.3
UEMS Session
The microenvironment of pituitary neuroendocrine tumors: focus on folliculostellate cells
Tue 21 12:45
ESE Annual General Meeting
Tue 21
EYIJC1
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
The metabolic effects of SGLT2 inhibitors – Does the increase in ketone bodies protect the heart?
Tue 21
EYIJC2
ESE Young Investigator Awards and Jens Sandahl Christansen Awards Ceremony
Role of hypothalamic AMP-activated protein kinase (AMPK) in the central regulation of energy balance
Tue 21 17:30
Closing Ceremony
L'Amphithéâtre
Sun 19 10:20
S1.1
Symposium 1: Thyroid in cancer
What is the value of molecular markers in nodules
Sun 19 10:50
S1.2
Symposium 1: Thyroid in cancer
Iodine refractoriness in thyroid cells
Birmingham, UK
Sun 19 11:20
S1.3
Symposium 1: Thyroid in cancer
New paradigms in the treatment of low risk thyroid cancer
Sun 19 10:20
S2.1
Symposium 2: Trends in Puberty
Exploring the Epigenetic Landscape of Puberty
Sun 19 10:50
S2.2
Symposium 2: Trends in Puberty
Endocrine disruptors in puberty
Liège, Belgium
Sun 19 11:20
S2.3
Symposium 2: Trends in Puberty
Genetic basis in puberty
London, UK
Sun 19 10:20
S3.1
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Circadian control of glucocorticoid function
Manchester, UK
Sun 19 10:50
S3.2
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Fixing the Broken Clock in Adrenal Disorders
Sun 19 11:20
S3.3
Symposium 3: Circadian clocks: from pathophysiology to chronomedicine
Light Up Your Sex Life!
Sun 19 10:50
S4.2
Symposium 4: Immunology and endocrinology
Clinical: Immunotherapy and endocrine disease
Sun 19 11:00
S4.3
Symposium 4: Immunology and endocrinology
Transitional: The diagnostic value of autoimmune antibodies in endocrine disorders
Stockholm, Sweden
Sun 19 11:20
S4.1
Symposium 4: Immunology and endocrinology
Basic: Immunotherapy and endocrine disease
Sun 19 10:20
S5.1
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Human gut microbiome: hopes, threats and promises
Sun 19 10:50
S5.2
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Fecal transplantation: Myth or reality
Sun 19 11:20
S5.3
Symposium 5: Microbiota as new treatment for diabetes and metabolic disease
Targeted Microbiome Intervention for handling insulin resistance
Sun 19 10:20
SS1.1
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Obesity gives you cancer: the bigger picture!
Sun 19 10:50
SS1.2
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Sleep Deficiency: A Pathway to Obesity
Sun 19 11:20
SS1.3
Special Symposium: ESE, the International Society of Endocrinology and the Endocrine Society Joint Session - OK, so that’s why; more insight into the ins and outs of obesity - 4th Joint Global Symposium on Obesity
Social economic impact of the globesity pandemic
Sun 19 13:45
Industry Sponsored Satellite Symposium
Forum 2
Sun 19 15:00
S6.1
Symposium 6: A better life with thyroid hormone
Prediction of the thyroid axis set-point
Sun 19 15:30
S6.2
Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in children
Sun 19 16:00
S6.3
Symposium 6: A better life with thyroid hormone
Subclinical hypothyroidism in the elderly
Newcastle, UK
Sun 19 15:00
S7.1
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Thyroid
Sun 19 15:30
S7.2
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Diabetes Mellitus
Sun 19 16:00
S7.3
Symposium 7: Endocrine Disrupting Chemicals
Endocrine Disrupting Chemicals and Obesity
Sun 19 15:00
S8.1
Symposium 8: Gender dysphoria
Psychoendocrinology Of Gender Dysphoria
Sun 19 15:30
S8.2
Symposium 8: Gender dysphoria
Gender Dysphoria –management of puberty
Ghent, Belgium
Sun 19 16:00
S8.3
Symposium 8: Gender dysphoria
Gender reassignment surgery in dysphoria
Sun 19 15:00
S9.3
Symposium 9: Controversies in adrenal disease
Is there a role for subtotal adrenalectomy
Sun 19 15:30
S9.1
Symposium 9: Controversies in adrenal disease
Metanephrines - plasma or urine?
Dresden , Germany
Sun 19 16:00
S9.2
Symposium 9: Controversies in adrenal disease
The do's and don'ts of genetic testing in phaeochromocytoma
Sun 19 15:00
S10.1
Symposium 10: Cancer drug-induced osteoporosis
Mechanisms of skeletal metastasis (could be induced by breast cancer or prostate cancer or both)
Dresden, Germany
Sun 19 15:30
S10.2
Symposium 10: Cancer drug-induced osteoporosis
Aromatase inhibitors and bone
Sun 19 16:00
S10.3
Symposium 10: Cancer drug-induced osteoporosis
TSH-suppressive therapy and bone
Sun 19 17:45
Industry Sponsored Satellite Symposium
Forum 1
Mon 20 10:20
S11.1
Symposium 11: EDCs and reproduction
Oocytes, Pesticides and IVF
Mon 20 10:50
S11.2
Symposium 11: EDCs and reproduction
Testicular germ cell cancer: role of fœtal exposure to endocrine disruptors
Mon 20 11:20
S11.3
Symposium 11: EDCs and reproduction
Mitigating against endocrine disruption in pregnancy
Copenhagen, Denmark
Mon 20 10:20
S12.1
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
The view of the surgeon: When, how much and when to refrain from surgery?
Mon 20 10:50
S12.2
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
New potential treatment alternatives in patients with papillary craniopharyngioma
Mon 20 11:20
S12.3
Symposium 12: Craniopharyngioma; a challenging tumour to treat and a difficult aftermath
How to manage the long-term consequences of hypothalamic damages
Mon 20 10:20
S13.1
Symposium 13: Central Control of Metabolism: Brain rules all
All optics in the metabolic brain
Mon 20 10:50
S13.2
Symposium 13: Central Control of Metabolism: Brain rules all
Role of mitochondria/cell bioenergetics in CNS regulation of energy balance
Mon 20 11:20
S13.3
Symposium 13: Central Control of Metabolism: Brain rules all
Genetics of appetite regulation
Cambridge, UK
Mon 20 10:20
S14.1
Symposium 14: Innovations in NETs
Innovative imaging of insulinoma: The end of sampling…
Mon 20 10:50
S14.2
Symposium 14: Innovations in NETs
A role for radionuclide therapy for high-grade NETs
Mon 20 11:20
S14.3
Symposium 14: Innovations in NETs
Fishing for NETs
Mon 20 10:20
S15.1
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Welcome and Introduction to EYES
Mon 20 10:25
S15.2
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Investigating glucocorticoids as the mechanism behind bone marrow adiposity expansion during caloric restriction
Mon 20 10:45
S15.3
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Mon 20 11:05
S15.4
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
The role and cross-talk between incretin hormones and occurrence of Nonalcoholic steatohepatitis
Mon 20 11:25
S15.5
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Lysophosphatidic acid in pathogenesis of HNF1B-MODY syndrome
Mon 20 11:45
S15.6
Symposium 15: European Young Endocrine Scientists (EYES) - Organ cross-talk in endocrine disease
Closing remarks
Mon 20 13:45
Industry Sponsored Satellite Symposium
Forum 2
Mon 20 15:00
S16.1
Symposium 16: Thyroid in pregnancy
Thyroid autoimmunity and fertility
Mon 20 15:30
S16.2
Symposium 16: Thyroid in pregnancy
Thyroid disease and pregnancy outcomes
Mon 20 16:00
S16.3
Symposium 16: Thyroid in pregnancy
Thyroid disease and offspring development
Mon 20 15:00
S17.1
Symposium 17: Where Do Pituitary Tumours Come From
Specification of cell fate
Montreal, Canada
Mon 20 15:30
S17.2
Symposium 17: Where Do Pituitary Tumours Come From
Pertubations in novel signalling pathways
London, UK
Mon 20 16:00
S17.3
Symposium 17: Where Do Pituitary Tumours Come From
From Lab to Clinic - Can we translate into effective therapeutics
Mon 20 15:00
S18.1
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
GnRH migration and vomeronasal neurons
Mon 20 15:30
S18.2
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Flipping the GnRH switch with microRNAs
Mon 20 16:00
S18.3
Symposium 18: Congenital Hypogonadotropic Hypogonadism: New insights into GnRH Regulation
Congenital Hypogonadotropic Hypogonadism: Clinical Perspectives
Mon 20 15:00
S19.1
Symposium 19: Adrenal Insufficiency
New insights into autoimmune adrenal insufficiency

Unknown speaker

Bergen, Norway
Mon 20 15:30
S19.2
Symposium 19: Adrenal Insufficiency
Long-term results of slow acting glucocorticoids - are they really better?
Mon 20 16:00
S19.3
Symposium 19: Adrenal Insufficiency
Optimising care delivery in Congenital Adrenal Hyperplasia
Sheffield, UK
Mon 20 15:00
S20.1
Symposium 20: News on Nutrition: When to eat what
Precision Nutrition for managing obesity – Does it work?
Mon 20 15:30
S20.2
Symposium 20: News on Nutrition: When to eat what
Is limiting the timing of food intake a viable nutritional approach?
Mon 20 16:00
S20.3
Symposium 20: News on Nutrition: When to eat what
PREDIMED Plus trial - energy-restricted Mediterranean diet plus exercise and metabolic health
Mon 20 18:00
Industry Sponsored Satellite Symposium
Salle Gratte-Ciel 1+2+3
Tue 21 09:50
S21.1
Symposium 21: Rare Bone Disorders
Animal model of bone fragility
Pavia, Italy
Tue 21 10:20
S21.2
Symposium 21: Rare Bone Disorders
New perspectives on the treatment of skeletal dysplasia
Paris, France
Tue 21 10:50
S21.3
Symposium 21: Rare Bone Disorders
Osteogenesis imperfecta throughout life
Oxford, UK
Tue 21 09:50
S22.1
Symposium 22: The Pituitary As Metabolic Sensor
Kiss1 as integrator of endocrine and metabolic function in the hypothalamic-pituitary axis
Tue 21 10:20
S22.2
Symposium 22: The Pituitary As Metabolic Sensor
How treatments with endocrine & metabolic drugs influence pituitary cell function?
Tue 21 10:50
S22.3
Symposium 22: The Pituitary As Metabolic Sensor
Bidirectional interrelationship between growth hormone and metabolism
Tue 21 09:50
S23.1
Symposium 23: PCOS: Can we personalise treatment?
Gut brain axis
Tue 21 10:20
S23.2
Symposium 23: PCOS: Can we personalise treatment?
Implicating androgen excess in metabolic disease in PCOS

Unknown speaker

Tue 21 10:50
S23.3
Symposium 23: PCOS: Can we personalise treatment?
Treatment options in cardiometabolic PCOS phenotype
Tue 21 09:50
S24.1
Symposium 24: What's new in the Adrenal Cortex?
New genes, new understanding, new therapy
Tue 21 10:20
S24.2
Symposium 24: What's new in the Adrenal Cortex?
Primary hyperaldosteronism: does our treatment work?
Tue 21 10:50
S24.3
Symposium 24: What's new in the Adrenal Cortex?
Autonomous cortisol secretion has cardiovascular consequences
Tue 21 14:30
S26.1
Symposium 26: Impact of thyroid disease on...
Role of thyroid hormones in the pathogenesis and treatment of psychiatric disorders
Tue 21 15:00
S26.2
Symposium 26: Impact of thyroid disease on...
Bone
Tue 21 15:30
S26.3
Symposium 26: Impact of thyroid disease on...
Cardiac hypertrophy
Tue 21 14:30
S27.1
Symposium 27: What's new in reproductive endocrinology?
Dissecting Androgens in PCOS
Tue 21 15:00
S27.2
Symposium 27: What's new in reproductive endocrinology?
Large scale genetic studies in male infertility
Tue 21 15:30
S27.3
Symposium 27: What's new in reproductive endocrinology?
Menopause and cardiovascular risk
Tue 21 14:30
S28.1
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and its metabolites
Tue 21 15:00
S28.2
Symposium 28: Vitamin D - non-skeletal effects in RCTs
Vitamin D and Type 1 Diabetes
Tue 21 15:30
S28.3
Symposium 28: Vitamin D - non-skeletal effects in RCTs
How and when to measure Vitamin D
Tue 21 14:30
S29.1
Symposium 29: Endocrine controversies in sport
Female hyperandrogenism and elite sport
Stockholm, Sweden
Tue 21 15:00
S29.2
Symposium 29: Endocrine controversies in sport
Performance enhancing drugs in young males
Tue 21 15:30
S29.3
Symposium 29: Endocrine controversies in sport
Omics to fight doping
Tue 21 14:30
S30.1
Symposium 30: Personalised medicine in diabetes and obesity
Mechanisms for Cardiovascular Complications of Diabetes – Implications for Personalized Therapy
Tue 21 15:00
S30.2
Symposium 30: Personalised medicine in diabetes and obesity
New avenues for novel drugs to treat obesity
Liverpool, United Kingdom
Tue 21 15:30
S30.3
Symposium 30: Personalised medicine in diabetes and obesity
Curing diabetes with alternatives: bariatric surgery
Sun 19 12:00
OC3.1
Oral Communications 3: Cushing's and acromegaly
Osilodrostat provides clinical benefit over 48 weeks in patients with Cushing disease: Results from the LINC 3 study
Sun 19 12:12
OC3.2
Oral Communications 3: Cushing's and acromegaly
Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres
Birmingham, UK
Sun 19 12:24
OC3.3
Oral Communications 3: Cushing's and acromegaly
Monosynaptic inputs to corticotropin-releasing hormone neuron in hypothalamic paraventricular nucleus of mice at the whole brain scale
Sun 19 12:36
OC3.4
Oral Communications 3: Cushing's and acromegaly
Restoration of basal glucose turnover after disease control in acromegaly depends on treatment modality: a prospective, investigator-initiated trial
Sun 19 12:48
OC3.5
Oral Communications 3: Cushing's and acromegaly
T2-signal intensity, SST receptor expression and first-generation somatostatin analogues efficacy predict hormone and tumor responses to pasireotide in acromegaly
Sun 19 12:00
OC4.1
Oral Communications 4: Thyroid 2
Subclinical hypothyroidism throughout pregnancy in TPOAb positive pregnant women
Sun 19 12:12
OC4.2
Oral Communications 4: Thyroid 2
Thyroid Dysfunction And Mortality In Cardiovascular Hospitalized Patients – A 12 year Follow-up Observational Study
Sun 19 12:24
OC4.3
Oral Communications 4: Thyroid 2
PROGNOSTIC IMPACT OF MICROSCOPIC EXTRATHYROIDAL EXTENSION (mETE) ON RECURRENCE-FREE SURVIVAL IN PATIENTS WITH PAPILLARY THYROID CARCINOMA (PTC)
Sun 19 12:36
OC4.4
Oral Communications 4: Thyroid 2
Cardiac and vascular characteristics of thyroid hormone resistance syndrome in France
Sun 19 12:48
OC4.5
Oral Communications 4: Thyroid 2
A comprehensive assessment of the interplay between the thyroid function and the immune system: results from the Human Functional Genomics Project
Sun 19 13:45
Industry Sponsored Satellite Symposium
Forum 1
Sun 19 13:45
Industry Sponsored Satellite Symposium
Salle Gratte-Ciel 1+2+3
Sun 19 17:45
Industry Sponsored Satellite Symposium
Forum 2
Sun 19 17:45
Industry Sponsored Satellite Symposium
Salle Gratte-Ciel 1+2+3
Sun 19 19:30
Informal Networking Evening
(Badge holders only)
Mon 20 12:00
OC9.1
Oral Communications 9: Thyroid 1
3D mapping and in silico predictions of the DEHAL1 enzyme as a tool to discriminate pathogenic mutations from non-functional variants in hypothyroidism
Mon 20 12:12
OC9.2
Oral Communications 9: Thyroid 1
Direct evidence for disulfides in the mechanism of deiodinase 1
Mon 20 12:24
OC9.3
Oral Communications 9: Thyroid 1
Novel driver mutations in thyroid cancer recurrence
Birmingham, United Kingdom
Mon 20 12:36
OC9.4
Oral Communications 9: Thyroid 1
Resistance to thyroid hormone alpha associated with early-onset severe NASH
Mon 20 12:48
OC9.5
Oral Communications 9: Thyroid 1
Deciphering the origin of the sexually dimorphic thyrotropin secretion in mouse models.
Mon 20 12:00
OC5.1
Oral Communications 5: Adrenal 2
Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma
Mon 20 12:12
OC5.2
Oral Communications 5: Adrenal 2
Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved
Mon 20 12:24
OC5.3
Oral Communications 5: Adrenal 2
SF3B1 as novel target for the treatment of multiple endocrine-related cancers
Mon 20 12:36
OC5.4
Oral Communications 5: Adrenal 2
The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy
Mon 20 12:48
OC5.5
Oral Communications 5: Adrenal 2
Impact of adrenal insufficiency on patient-centred health care outcomes in adult medical inpatients
Mon 20 12:00
OC6.1
Oral Communications 6: Obesity 1
Impaired Glucose Homeostasis in Leptin-Deficient ob/ob Mice is Corrected by AZP-3404, a 9-Amino Acid Peptide Analog Derived from Insulin-Like Growth Factor-Binding Protein 2, a Key Mediator of Leptin Action
Mon 20 12:12
OC6.2
Oral Communications 6: Obesity 1
Deep Transcranial Magnetic Stimulation modulates body temperature in obesity
Mon 20 12:24
OC6.3
Oral Communications 6: Obesity 1
Role of hypothalamic bile acid-TGR5 signaling in the regulation of energy balance
Mon 20 12:36
OC6.4
Oral Communications 6: Obesity 1
Fat mass impact of Sirolimus after clinical islet transplantation, a case control study
Mon 20 12:48
OC6.5
Oral Communications 6: Obesity 1
Lipolysis Defect in White Adipose Tissue and Rapid Weight Regaining
Mon 20 12:00
OC7.1
Oral Communications 7: Endocrine Connections
Cortisol suppression or peripheral sensitivity and activation are associated with diabetes, hypertension and fragility fractures in postmenopausal eucortisolemic women
Mon 20 12:12
OC7.2
Oral Communications 7: Endocrine Connections
Thyroid hormones are new key regulators of glucocorticoid metabolism
Mon 20 12:24
OC7.3
Oral Communications 7: Endocrine Connections
HIGHER DOSE OF BUROSUMAB IS NEEDED FOR TREATMENT OF CHILDREN WITH SEVER FORMS OF X-LINKED HYPOPHOSPHATEMIA
Mon 20 12:36
OC7.4
Oral Communications 7: Endocrine Connections
Non-invasive detection of GNAS mutations causing McCune-Albright Syndrome with ddPCR on whole blood or circulating DNA.
Mon 20 12:48
OC7.5
Oral Communications 7: Endocrine Connections
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome : French prospective study in a cohort of 25 patients
Mon 20 13:00
ERN1.1
Endo-ERN Session - Lunch Hub
Introduction and update on Endo-ERN
Mon 20 13:01
ERN1.2
Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Mon 20 13:02
ERN1.3
Endo-ERN Session - Lunch Hub
Core activities of Endo-ERN in close collaboration with ESE and ESPE: the multi-disciplinary approach
Mon 20 13:45
Industry Sponsored Satellite Symposium
Forum 3
Mon 20 13:45
Industry Sponsored Satellite Symposium
Auditorium Lumière
Tue 21 11:30
OC11.1
Oral Communications 11: Diabetes 2
Hormonal factors and type 2 diabetes risk in women: a 22 year follow-up study on more than 83 000 women from the E3N cohort study
Tue 21 11:42
OC11.2
Oral Communications 11: Diabetes 2
Molecular Mechanisms Regulating Hepatic Sex Hormone-Binding Globulin Production. Clinical Implications in Human Diseases.
Tue 21 11:54
OC11.3
Oral Communications 11: Diabetes 2
Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes
Tue 21 12:06
OC11.4
Oral Communications 11: Diabetes 2
MiR-30e-5p expression is downregulated in plasma and urine of type 1 diabetic patients with diabetic kidney disease
Tue 21 12:18
OC11.5
Oral Communications 11: Diabetes 2
Bone metabolism and circulating myeloid calcifying cells in diabetic post menopausal women: a case-control study
Tue 21 11:30
OC12.1
Oral Communications 12: Endocrine Connections 2
Weekly shifts in light-dark cycle disrupt circadian clock gene expression in bone and reduce bone turnover
Tue 21 11:42
OC12.2
Oral Communications 12: Endocrine Connections 2
Epigenetic Programming of Transgenerational Hypertension in Preterm Birth Mice
Tue 21 11:54
OC12.3
Oral Communications 12: Endocrine Connections 2
Neuronostatin and GPR107 system: a novel therapeutic circuit in Prostate Cancer.
Tue 21 12:06
OC12.4
Oral Communications 12: Endocrine Connections 2
Long-term follow-up of antitumoral immunotherapy- induced hypophysitis in Lille hospital, France
Tue 21 12:18
OC12.5
Oral Communications 12: Endocrine Connections 2
Sexual desire in transgender persons in relation with gender affirming hormone treatment. Results from ENIGI, a large multicenter prospective cohort study in transgender people
Tue 21 11:30
OC13.1
Oral Communcations 13: Anteria and posteria pituitary
Arginine-stimulated Copeptin Measurements - A new Test for Diabetes Insipidus
Tue 21 11:42
OC13.2
Oral Communcations 13: Anteria and posteria pituitary
Empagliflozin increases sodium-levels in patients with the syndrome of inappropriate antidiuretic hormone secretion – a randomized, double-blind, placebo-controlled trial
Tue 21 11:54
OC13.3
Oral Communcations 13: Anteria and posteria pituitary
Pituitary tumour-derived chemokines modulate immune cell infiltrates in the tumour microenvironment leading to aggressive phenotype
Tue 21 12:06
OC13.4
Oral Communcations 13: Anteria and posteria pituitary
Pharmacokinetics of somapacitan in individuals with hepatic impairment: an open-label, parallel group, phase 1 study
Tue 21 12:18
OC13.5
Oral Communcations 13: Anteria and posteria pituitary
Pan-genomic classification of Pituitary Adenomas
Tue 21 11:30
OC14.1
Oral Communications 14: Sex Hormones
Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial
Tue 21 11:42
OC14.2
Oral Communications 14: Sex Hormones
The effect of testosterone therapy on serum oestradiol levels in transgender men
Tue 21 11:54
OC14.3
Oral Communications 14: Sex Hormones
First identification of Bone Morphogenic Protein Receptor variants as a cause of Primary Ovarian Insufficiency
Tue 21 12:06
OC14.4
Oral Communications 14: Sex Hormones
Thyroid diseases in Danish women with polycystic ovary syndrome.
Tue 21 12:18
OC14.5
Oral Communications 14: Sex Hormones
The pattern of cancer occurrence in Turner syndrome
Tue 21 13:00
EU research funding - overview of opportunities and insights towards a successful application
ECE HUB - Exhibition area
Chairs: Felix Beuschlein (Switzerland) & Valerie Handweiler (France)
Hub 1.6

0 result(s) found.